Skip to main content

Table 2 Perioperative Variables

From: Impact of total intravenous anesthesia and total inhalation anesthesia as the anesthesia maintenance approaches on blood glucose level and postoperative complications in patients with type 2 diabetes mellitus: a double-blind, randomized controlled trial

 

TIVA Group

TIHA Group

P Value

 

(n = 56)

(n = 60)

 

Operation time (h)

3 [2.2, 3.8]

3 [2.3, 3.8]

0.158

Anesthesia time (h)

4.65 [2.8, 6.6]

4.41 [2.6, 6.2]

0.412

Surgery

   

 Gastrointestinal surgery

27

31

0.710

 Liver surgery

16

18

0.866

 Biliary tract surgery

4

4

0.919

 Thyroid mammary surgery

6

4

0.438

 Urinary surgery

3

3

0.931

Intraoperative infusion (ml)

   

   Crystalloids

1500 [1100, 1800]

1650 [1100, 2075]

0.069

   Colloids

500 [500, 1000]

500 [500, 1000]

0.185

Urine output (ml)

500 [200, 700]

450 [300, 738]

0.986

Blood transfusion (n)

4 (7.1)

8 (14.2)

0.222

Remifentanil (µg)

1782 [1130, 2022]

1619 [1008, 1909]

0.903

Sufentanil (µg)

32.5 [27.5, 37.5]

32.5 [27.3, 40.0]

0.535

Insulin use (n)

   

 Introperative period

5 (8.9)

8 (13.3)

0.452

 POD 0

1 (1.8)

6 (10.0)

0.063

 POD 1

5 (8.9)

12 (20.0)

0.092

 POD 2

3 (5.3)

4 (6.7)

0.767

Hyperglycemia (n)

   

 Introperation

6 (10.7)

16 (26.6)

0.032

 Postoperation

10 (17.8)

20 (33.3)

0.057

  1. The data are expressed as n (%) or median [range]. The P values were calculated by the Mann-Whiney U test, chi-square test, or Fisher exact test. TIVA, total intravenous anesthesia; TIHA, total inhalation anesthesia; POD, postoperative day
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us